Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Larimar Therapeutics | LRMR | Sep 27, 2024 | 6.57 | +3.79 |
Las Vegas Sands | LVS | Sep 27, 2024 | 51.12 | +5.62 |
Laser Photonics | LASE | Sep 27, 2024 | 14.34 | +12.91 |
Latham Group | SWIM | Sep 27, 2024 | 6.74 | +2.28 |
Latin America Alphadex First Trust | FLN | Sep 27, 2024 | 18.34 | +0.33 |
Lattice Semiconductor | LSCC | Sep 27, 2024 | 53.52 | -1.60 |
Launch One Acquisition | LPAA | Sep 27, 2024 | 9.97 | 0.00 |
Launch One Acquisition | LPAAU | Sep 27, 2024 | 10.00 | 0.00 |
Laureate Education | LAUR | Sep 27, 2024 | 16.65 | +0.67 |
LAVA Therapeutics | LVTX | Sep 27, 2024 | 1.68 | +1.70 |
Lavoro | LVRO | Sep 27, 2024 | 3.80 | +2.98 |
Lazard A | LAZ | Sep 27, 2024 | 50.43 | +0.24 |
Lazard Global Total Return and Income Fund | LGI | Sep 27, 2024 | 18.19 | +1.51 |
Lazydays | GORV | Sep 27, 2024 | 1.47 | +2.08 |
LCI Industries | LCII | Sep 27, 2024 | 120.04 | +1.12 |
LCNB | LCNB | Sep 27, 2024 | 15.05 | +1.69 |
Lead Real Estate ADR | LRE | Sep 27, 2024 | 1.60 | +1.27 |
Leafly | LFLY | Sep 27, 2024 | 2.18 | +0.46 |
Leap Therapeutics | LPTX | Sep 27, 2024 | 2.70 | +2.66 |
Lear | LEA | Sep 27, 2024 | 112.72 | +1.91 |
Learn CW Investment SPAC | LCW | Sep 27, 2024 | 10.98 | 0.00 |
LeddarTech | LDTC | Sep 27, 2024 | 0.32 | +1.43 |
Lee Enterprises | LEE | Sep 27, 2024 | 8.79 | -1.24 |
Legacy Housing | LEGH | Sep 27, 2024 | 27.41 | -0.36 |
LegalZoom.com | LZ | Sep 27, 2024 | 6.47 | -2.12 |
Legato Merger III | LEGT | Sep 27, 2024 | 10.21 | +0.04 |
Legend Biotech ADR | LEGN | Sep 27, 2024 | 49.27 | +5.17 |
Legg Mason Low Volatility High Dividend ETF | LVHD | Sep 27, 2024 | 40.55 | +0.52 |
Leggett & Platt | LEG | Sep 27, 2024 | 14.12 | +3.75 |
Leidos | LDOS | Sep 27, 2024 | 159.72 | +0.81 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.